Is Cogent Biosciences, Inc. (COGT) a Buy, Sell, or Hold?
NASDAQ : COGT
Cogent Biosciences, Inc. — Analyst Ratings
$38.93 USD
-$2.43 (-5.88%)
- Volume
- 1.52M
- Average Volume
- 2.45M
- Market Capitalization
- $6.65B
- P/E Ratio
- -12.64
- Dividend Yield
- 0.00%
- Price Target
- $48.50
- Year High
- $43.73
- Year Low
- $10.38
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $15.14
Analyst Consensus Summary
Consensus Rating
Strong Sell
12 Analysts
Rating Score
1/5
Recommendation Strength
Upside/Downside
-19.7%
vs Current Price
Price Target
$48.50
Average TargetPrice Target Range
Lowest Target
$35.00
11.2% UPSIDE
Average Target
$48.50
Median Estimate
Highest Target
$55.00
-29.2% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 12
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 10 | 2 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Stifel Nicolaus | Laura Prendergast | $45 | $34.96 | 2026-06-01 07:31 AM | 28.7% |
| H.C. Wainwright | Robert Burns | $55 | $36.98 | 2026-05-06 06:14 AM | 48.7% |
| UBS | Michael Yee | $60 | $34.78 | 2026-01-07 12:41 AM | 72.5% |
| Raymond James | Chris Raymond | $60 | $32.46 | 2025-11-11 04:27 AM | 84.8% |
| Wedbush | David Nierengarten | $38 | $34.7573 | 2025-11-10 10:19 AM | 9.3% |